Overview

This enduring webcast shares highlights from a live presentation at AARC Congress 2016, which took place in San Antonio, TX on Sunday, October 16th. Dr. Joyce Lee and Respiratory Therapist, Trina Limberg discuss the spectrum of idiopathic pulmonary fibrosis (IPF), changing treatment paradigms for IPF patients and how respiratory therapists can better assist IPF patients and their caregivers. 

This activity is intended for respiratory therapists and other clinicians involved in the management of patients with IPF.

Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients' quailty of life and diminishes life expectancy. New therapies are available that slow function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. This program will discuss the prevalence, signs and symptoms, and diagnostic criteria for IPF as well as compare and contrast available therapies and formulate strategies for comprehensive management of symptoms. 

Upon completion of this activity, participants will be able to:
• Outline the prevalence, signs and symptoms, and diagnostic criteria for IPF
• Compare and contrast available therapies for IPF
• Formulate strategies for comprehensive management of symptoms
• Effectively counsel IPF patients on available therapies and supportive care
• Identify patients with IPF who may benefit from intensification of therapy

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.